New Malaysian evidence for cancer nutrition care underpins Pharm-D Health Science-NCSM’s ‘1,000 Cans of Hope’ initiative
KUALA LUMPUR, Sept 8 — When Puan Suzana was diagnosed with breast cancer, she expected chemotherapy to be the toug...
Malaysian breast cancer patient Puan Suzana found that eating became a major challenge during her treatment. She relied on Valens Onthera+, a specialised immunonutrition formula, to help her maintain her strength and energy. A recent Malaysian clinical study has shown that patients receiving immunonutrition, such as Valens Onthera+, had better clinical outcomes, including shorter hospital stays, faster recovery, improved wound healing, and zero hospital readmissions within 30 days after surgery.
This evidence highlights the importance of perioperative immunonutrition in cancer care, beyond the data primarily drawn from Western and East Asian populations. To support patients in Malaysia who struggle with nutritional challenges during their cancer journey, the Valens Onthera+ "1,000 Cans of Hope" initiative was launched. This initiative, launched at the Psychosocial Support Summit in conjunction with the National Cancer Congress Malaysia 2026, provides 1,000 cans of Valens Onthera+ immunonutrition formula to eligible patients identified through NCSM via comprehensive nutritional assessments and clinical consultations.
Written by urgent.news from Malay Mail's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
